pancreaticoduodenal carcinoma (pancreatic tumor, distal cholangiocarcinoma, ampullary carcinoma)
Conditions
Interventions
Intake of Elental(R) from 7-10 days before operation to the day before operation and oral carbohydrate-containing fluid in the operation day
Sponsors
Keio University School of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1)Patients with pancreaticoduodenal tumor (pancreatic tumor, bile duct tumor, ampullary tumor) (2)Patients who will undergo Pancreaticoduodenectomy (3)Performance status: 0-2 (4)Patients who fully understand the study procedures and consent the document voluntary after an adequate explanation (5)Patients who underwent pancreaticoduodenectomy before this study running (control arm)
Exclusion criteria
Exclusion criteria: (1) sever diabetes mellitus, disorder of carbohydrate metabolism due to high dose steroid (2) disorder of amino acid metabolism (3) allergy to Elental(R) (4) Patients who are pregnant or hope to be pregnant (5) Patients who offer discontinuation of the study (6) Patients who are judged as inadequate to participate the study by the their doctors
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the postoperative complications rate | — |
Secondary
| Measure | Time frame |
|---|---|
| first-year recurrence free survival, body weight, serum albumin, total lymphocyte count, total cholesterol, cholinesterase, CRP, HbA1c, insulin dose (if the patient use insulin injection) | — |
Countries
Japan
Contacts
Public ContactMinoru Kitago
Keio University School of Medicine Department of Surgery
Outcome results
None listed